Rheumatoid arthritis and anaesthesia

Anaesthesia

Volumn 66, Issue 12, 2011, Pages 1146-1159

  Samanta, R ^a   Shoukrey, K ^b   Griffiths, R ^a  

^a PETERBOROUGH CITY HOSPITAL   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; ADALIMUMAB; AZATHIOPRINE; CERTOLIZUMAB PEGOL; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; CYCLOSPORIN A; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; GOLD SALT; GOLIMUMAB; HLA DR ANTIGEN; HYDROCORTISONE; HYDROXYCHLOROQUINE; INFLIXIMAB; INTERLEUKIN 1; LEFLUNOMIDE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RHEUMATOID FACTOR; RITUXIMAB; SALAZOSULFAPYRIDINE; TOCILIZUMAB; TUMOR NECROSIS FACTOR ALPHA;

ANESTHESIA; ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; ARTHRALGIA; ATLANTOAXIAL SUBLUXATION; BODY MASS; BREATHING EXERCISE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR RISK; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CERVICAL SPINE; CHEST INFECTION; COMPUTER ASSISTED TOMOGRAPHY; CONGESTIVE HEART FAILURE; DISEASE DURATION; DISEASE SEVERITY; DRUG COST; DRUG EFFICACY; DRUG SAFETY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ENDOTRACHEAL INTUBATION; EYE TOXICITY; GASTROINTESTINAL SYMPTOM; GENERAL ANESTHESIA; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GLOMERULONEPHRITIS; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; INTERSTITIAL LUNG DISEASE; JOINT DESTRUCTION; JOINT FUNCTION; JOINT RADIOGRAPHY; JOINT STIFFNESS; JOINT SWELLING; LARYNGEAL MASK; LARYNGOSCOPY; LIVER TOXICITY; LYMPHADENOPATHY; LYMPHOMA; MORNING STIFFNESS; MUSCLE ATROPHY; NEPHROTOXICITY; PALLIATIVE THERAPY; PANCREATITIS; PATHOGENICITY; PATIENT CONTROLLED ANALGESIA; PEPTIC ULCER; PERIPHERAL NEUROPATHY; PEROPERATIVE CARE; PHYSIOTHERAPY; PNEUMONIA; POSTOPERATIVE CARE; PREOPERATIVE CARE; REGIONAL ANESTHESIA; RESPIRATION CONTROL; REVIEW; RHEUMATOID ARTHRITIS; SMOKING; SPINAL ANESTHESIA; STEVENS JOHNSON SYNDROME; SURGICAL STRESS; TEMPOROMANDIBULAR JOINT; THROMBOSIS PREVENTION; TOTAL KNEE REPLACEMENT; TRACHEOSTOMY; VENOUS THROMBOEMBOLISM;

AIRWAY MANAGEMENT; ANESTHESIA; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; BIOLOGICAL AGENTS; CYTOKINES; HUMANS; METHOTREXATE;

EID: 81055144271     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/j.1365-2044.2011.06890.x     Document Type: Review

References (64)

1. Baka Z, Buzás E, Nagy G,. Rheumatoid arthritis and smoking: putting the pieces together. Arthritis Research and Therapy 2009; 11: 238.
2. Barton A, Worthington J,. Genetic susceptibility to rheumatoid arthritis: an emerging picture. Arthritis and Rheumatism 2009; 61: 1441-6.
3. Bowes J, Barton A,. Recent advances in the genetics of RA susceptibility. Rheumatology 2008; 47: 399-402.
4. Aletaha D, Neogi T, Silman AJ, et al., 2010 rheumatoid arthritis classification criteria. Arthritis and Rheumatism 2010; 62: 2569-81.
5. Choy EHS, Panayi GS,. Cytokine pathways and joint inflammation in rheumatoid arthritis. New England Journal of Medicine 2001; 344: 907-16. (Pubitemid 32224400)
6. Lee DM, Kiener HP, Agarwal SK, et al., Cadherin-11 in synovial lining formation and pathology in arthritis. Science 2007; 315: 1006-10. (Pubitemid 46281192)
7. Chang SK, Gu Z, Brenner MB,. Fibroblast-like synoviocytes in inflammatory arthritis pathology: the emerging role of cadherin-11. Immunological Reviews 2010; 233: 256-66.
8. Shingu M, Nagai Y, Isayama T, et al., The effects of cytokines in metalloproteinase inhibitors (TIMP) and collagenase production by human chondrocytes in TIMP production by synovial cells and endothelial cells. Clinical and Experimental Immunology 1993; 94: 145-9. (Pubitemid 23308380)
9. Klimiuk PA, Sierakowski S, Latosiewicz R, et al., Circulating tumour necrosis factor alpha and soluble tumour necrosis factor receptors in patients with different patterns of rheumatoid synovitis. Annals of the Rheumatic Diseases 2003; 62: 472-5. (Pubitemid 36469742)
10. Weinblatt ME, Kavanaugh A, Genovese MC, et al., An oral spleen tyrosine kinase (Syk) inhibitor for rheumaoid arthritis. New England Journal of Medicine 2010; 363: 1303-12.
11. van Oosterhour M, Bajema I, Levarht EWN, et al., Differences in synovial tissue infiltrates between anti-cyclic citrullinated peptide-positive rheumatoid arthritis and anti-cyclic citrullinated peptide-negative rheumatoid arthritis. Arthritis and Rheumatism 2008; 58: 53-60.
12. Neva MH, Hakkinen A, Makinen H, et al., High prevalence of asymptomatic cervical spine subluxation in patients with rheumatoid arthritis waiting for orthopaedic surgery. Annals of the Rheumatic Diseases 2006; 65: 884-8.
13. van Eijk IC, Nielen MMJ, van Soesberge RM, et al., Cervical spine involvement is rare in early arthritis. Annals of the Rheumatic Diseases 2006; 65: 973-4.
14. Laiho K, Soini I, Kautiainen H, et al., Can we rely on magnetic resonance imaging when evaluating unstable atlantoaxial subluxation. Annals of the Rheumatic Diseases 2003; 62: 254-6. (Pubitemid 36238092)
15. Hamilton JD, Gordon MM, McInnes IB, et al., Improved medical and surgical management of the cervical spine disease in patients with rheumatoid arthritis over 10 years. Annals of the Rheumatic Diseases 2000; 59: 434-8. (Pubitemid 30395600)
16. Karhu JO, Parkkola RK, Koskinen SK,. Evaluation of flexion/extension of the upper cervical spine in patients with rheumatoid arthritis: an MRI study with a dedicated positioning device compared to conventional radiographs. Acta Radiologica 2005; 46: 55-66. (Pubitemid 41673289)
17. Nguyen HV, Ludwig SC, Silber J, et al., Rheumatoid arthritis of the cervical spine. Spine Journal 2004; 4: 329-34. (Pubitemid 38559924)
18. Kolman J, Morris I,. Cricoarytenoid arthritis: a cause of acute upper airway obstruction in rheumatoid arthritis. Canadian Journal of Anesthesia 2002; 49: 729-32. (Pubitemid 35203679)
19. Gonzalez A, Maradit-Kremers A, Crowson CS, et al., The widening mortality gap between rheumatoid arthritis patients and the general propulation. Arthritis and Rheumatism 2007; 57: 3583-7. (Pubitemid 350100691)
20. del Rincon ID, Williams K, Stern MP, et al., High incidence of cardiovascular events in rheumatoid arthritis cohort not explained by traditional risk factors. Arthritis and Rheumatism 2001; 44: 2737-45. (Pubitemid 34016192)
21. Turesson C, Janrenros A, Jacobsson L,. Increased incidence of cardiovascular disease in patients with rheumatoid arthritis: results from a community based study. Annals of the Rheumatic Diseases 2004; 63: 952-5. (Pubitemid 38961920)
22. Peters MJ, van Halm VP, Voskuyi AE, et al., Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study. Arthritis and Rheumatism 2009; 61: 1571-9.
23. Aubry MC, Maradit-Kremers H, Renialda MS, et al., Differences in atherosclerotic coronary heart disease between subject with and without rheumatoid arthritis. Journal of Rheumatology 2007; 34: 937-42. (Pubitemid 46774835)
24. Ku IA, Imboden JB, Hsue PY, et al., Rheumatoid Arthritis-A model of systemic inflammation driving atherosclerosis. Circulation Journal 2009; 73: 977-85.
25. Roman MJ, Devereux RB, Scwartz JE, et al., Arterial stiffness in chronic inflammatory diseases. Hypertension 2005; 46: 194-9. (Pubitemid 40946513)
26. Gabazza EC, Osamu T, Yamakami T, et al., Correlation between clotting and collagen metabolism markers in rheumatoid arthritis. Thrombosis and Haemostasis 1994; 71: 199-202. (Pubitemid 24047327)
27. Kwasny-Krochin B, Gluszko P, Undas A,. Unfavourably altered fibrin clot properties in patient with active rheumatoid arthritis. Thrombosis Research 2010; 126: e11-6.
28. Gabriel SE,. Why do persons with rheumatoid arthritis still die prematurely? Annals of the Rheumatic Diseases 2008; 67 (Suppl 3): 30-4.
29. Barnabe C, Martin BJ, Ghali W,. Systematic review and meta-analysis: anti-tumour necrosis factor alpha therapy and cardiovascular events in rheumatoid arthritis. Arthritis Care and Research 2011; 63: 522-9.
30. Nicola PJ, Maradit-Kramers H, Roger VL, et al., The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years. Arthritis and Rheumatism 2005; 52: 412-20. (Pubitemid 40216304)
31. Rudominer RL, Roman MJ, Devereux RB, et al., Independent association of rheumatoid arthritis with increased left ventricular mass but not with reduced ejection fraction. Arthritis and Rheumatism 2009; 60: 22-9.
32. Giles JT, Malayeri AA, Fernandes V, et al., Left ventricular structure and function in patients with rheumatoid arthritis as assessed by cardiac magnetic resonance imaging. Arthritis and Rheumatism 2010; 62: 940-951.e.
33. Maradit-Kremers H, Nicola PJ, Crowson CS, et al., Prognostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritis. Arthritis and Rheumatism 2004; 50: 3450-7. (Pubitemid 39488669)
34. Ermens AAM, Schoester M, Spijkers LJM, et al., Toxicity of methotrexate in rats preexposed to nitrous oxide. Cancer Research 1989; 49: 6337-41. (Pubitemid 20000933)
35. Fiskerstrand T, Ueland PR, Refsum H,. Folate depletion induced by methotrexate affects methionine synthase activity and its susceptibility to inactivation by nitrous oxide. Journal of Pharmacology and Experimental Therapeutics 1997; 282: 1305-11. (Pubitemid 27408308)
36. Weaver AL,. The impact of new biologicals in the treatment of rheumatoid arthritis. Rheumatology 2004; 43 (Suppl 3): 17-23.
37. Brennan A, Bansback N, Nixon R, et al., Modelling the cost effectiveness of TNF-alpha antagonists in the management of rheumatoid arthritis: results from the British Society of Rheumatology Biologics Registry. Rheumatology (Oxford) 2007; 46: 1345-54. (Pubitemid 47244512)
38. Lekander I, Borgstrom F, Svarvar P, et al., Cost-effectiveness of real-world infliximab use in patients with rheumatoid arthritis in Sweden. International Journal of Technology Assessment in Health Care 2010; 26: 54-61.
39. Doan QV, Chiu CF, Dubois RW,. Review of eight pharmacoeconomic studies of the value of biologic DMARDs (adalimumab, etanercept and infliximab) in the management of rheumatoid arthritis. Journal of Managed Care Pharmacy 2006; 12: 555-69. (Pubitemid 47400571)
40. Bongartz T, Sutton AJ, Sweeting MJ, et al., Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies. Journal of the American Medical Association 2006; 295: 2275-85.
41. Rahier J-F, Moutschen M, Van Gompel A, et al., Vaccinations in patients with immune-mediated inflammatory diseases. Rheumatology 2010; 49: 1815-27.
42. Calder I, Calder J, Crockard HA,. Difficult direct laryngoscopy in patients with cervical spine disease. Anaesthesia 1995; 50: 756-63.
43. Fombon FN, Thompson JP,. Anaesthesia for the adult patient with rheumatoid arthritis. Continuing Education Anaesthesia, Critical Care and Pain 2006; 6: 235-9. (Pubitemid 44823697)
44. Tokunaga D, Hase H, Mikami Y, et al., Atlantoaxial subluxation in different intra-operative head positions in patients with rheumatoid arthritis. Anesthesiology 2006; 104: 675-9.
45. Sugimoto Y, Tanaka M, Nakanishi K, et al., Assessing the range of cervical rotation in patients with rheumatoid arthritis after atlantoaxial screw fixation using axial CT. Spine 2007; 32: 2318-21. (Pubitemid 47508838)
46. Urakami Y, Takenaka I, Nakamura M, et al., The reliability of the Bellhouse test for evaluating extension capacity of the occipitoatlantoaxial complex. Anesthesia and Analgesia 2002; 95: 1437-41. (Pubitemid 35239154)
47. Takenaka I, Iwagaki T, Aoyama K, et al., Preoperative evaluation of extension capacity of the occipitoatlantoaxial complex in patients with rheumatoid arthritis: comparison between the Bellhouse test and a new method, hyomental distance ratio. Anesthesiology 2006; 104: 680-5.
48. Kwek TK, Lew TW, Thoo FL,. The role of pre-operative cervical spine X-rays in rheumatoid arthritis. Anaesthesia and Intensive Care 1998; 26: 636-41. (Pubitemid 29011918)
49. Campbell RS, Wou P, Watt I,. A continuing role for pre-operative cervical spine radiography in rheumatoid arthritis? Clinical Radiology 1995; 50: 157-9.
50. Choi D, Casey ATH, Crockard HA,. Neck problems in rheumatoid arthritis-changing disease patterns, surgical treatments and patients' expectations. Rheumatology 2006; 45: 1183-4. (Pubitemid 44542055)
51. Kamanli A, Gok U, Sahin S, et al., Bilateral cricoarytenoid joint involvement in rheumatoid arthritis: a case report. Rheumatology 2001; 40: 593-4.
52. Fujiwara S, Nakamura I, Higo R, et al., Repeated postoperative laryngeal obstruction due to bilateral cricoarytenoid joint involvement in rheumatoid arthritis. Modern Rheumatology 2005; 15: 123-5. (Pubitemid 40823386)
53. Scanzello CR, Figgie MP, Nestor BJ, et al., Peri-operative management of medications used in the treatment of rheumatoid arthritis. HSS Journal 2006; 2: 141-7. (Pubitemid 44328110)
54. Giles JT, Bartlett SJ, Gelber AC, et al., Tumor necrosis factor inhibitor therapy and risk of serious postoperative orthopedic infection in rheumatoid arthritis. Arthritis and Rheumatism 2006; 55: 333-7.
55. Hirano Y, Kojima T, Kanayama Y, et al., Influences of anti-tumour necrosis factor agents on postoperative recovery in patients with rheumatoid arthritis. Clinical Rheumatology 2010; 29: 495-500.
56. Leino KA, Kuusniemi KS, Pälve HK, et al., Spread of spinal block in patients with rheumatoid arthritis. Acta Anaesthesiologica Scandanavica 2010; 54: 65-9.
57. Calder I,. Airway management in cervical spine disease. In:, Calder I, Pearce A, eds. Core Topics in Airway Management, 2nd edn. Cambridge: Cambridge University Press, 2010: 244-54.
58. Hakala P, Randell T,. Intubation difficulties in patients with rheumatoid arthritis A retrospective analysis. Acta Anaesthesiologica Scandanavica 1998; 42: 195-8. (Pubitemid 28067884)
59. Hindman BJ, Palecek JP, Ponser KL, et al., Cervical spinal cord, root, and bony spine injuries: a closed claims analysis. Anesthesiology 2011; 114: 782-95.
60. Nicholson G, Burrin JM, Hall GM,. Peri-operative steroid supplementation. Anaesthesia 1998; 53: 1091-104. (Pubitemid 28505344)
61. Chen JJ, Branstetter BF, Myers EN,. Cricoarytenoid rheumatoid arthritis: an important consideration in aggressive lesions of the larynx. American Journal of Neuroradiology 2005; 26: 970-2. (Pubitemid 43079802)
62. Lehmann T, Nef W, Stalder B, et al., Fatal postoperative airway obstruction in a patient with rheumatoid arthritis. Annals of the Rheumatic Diseases 1997; 56: 512-3. (Pubitemid 27428472)
63. Segebarth PB, Limbird TJ,. Peri-operative acute upper airway obstruction secondary to severe rheumatoid arthritis. Journal of Arthroplasty 2007; 22: 916-9. (Pubitemid 47361647)
64. Mukubo Y, Kawamata M,. Peri-operative hypercoagulability in patients with rheumatoid arthritis: Sonoclot study. Journal of Anesthesia 2004; 18: 62-4. (Pubitemid 38489054)